Vivani Medical (VANI) Other financing activities (2014 - 2024)

Vivani Medical (VANI) posted quarterly Other financing activities of $3000.0 for Q1 2024, down 86.96% quarter-over-quarter from $23000.0 in Q4 2023.

Vivani Medical (VANI) Other financing activities (2014 - 2024) Analysis & Trends

Vivani Medical's Other financing activities history runs 6 years deep, the most recent figure standing at $3000.0 for Q1 2024.

In Q1 2024, Other financing activities changed N/A year-over-year to $3000.0; the TTM figure through Mar 2024 stood at $129000.0 (changed N/A YoY), while the FY2023 annual figure was $133000.0, changed N/A from the prior year.
Other financing activities for Q1 2024 stood at $3000.0, down from $23000.0 in the prior quarter.
The five-year high for Other financing activities was $103000.0 in Q3 2023, with the low at $3000.0 in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Vivani Medical	122.36 Mn	102.47 Mn	-

Download Data